share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  10/09 20:31

Moomoo AI 已提取核心信息

On October 4, 2024, 180 Life Sciences Corp. announced it had regained compliance with Nasdaq's minimum shareholder equity requirement, following a decision by the Nasdaq Hearing Panel on July 1, 2024. The company will be monitored for one year to ensure ongoing compliance. However, 180 Life Sciences remains non-compliant with Nasdaq's audit committee requirements, specifically the need for at least three independent directors. The company has until the earlier of its next annual shareholders' meeting or May 7, 2025, to meet this requirement, with a deadline of November 4, 2024, if the shareholders' meeting occurs before that date. Failure to comply may lead to delisting, but the company is actively seeking qualified independent directors to regain compliance. Additionally, on October 9, 2024, 180 Life Sciences issued a press release about...Show More
On October 4, 2024, 180 Life Sciences Corp. announced it had regained compliance with Nasdaq's minimum shareholder equity requirement, following a decision by the Nasdaq Hearing Panel on July 1, 2024. The company will be monitored for one year to ensure ongoing compliance. However, 180 Life Sciences remains non-compliant with Nasdaq's audit committee requirements, specifically the need for at least three independent directors. The company has until the earlier of its next annual shareholders' meeting or May 7, 2025, to meet this requirement, with a deadline of November 4, 2024, if the shareholders' meeting occurs before that date. Failure to comply may lead to delisting, but the company is actively seeking qualified independent directors to regain compliance. Additionally, on October 9, 2024, 180 Life Sciences issued a press release about its re-compliance with the Equity Rule and its strategic shift towards the iGaming sector, following the acquisition of a leading iGaming platform technology. The company aims to leverage this technology to enter the rapidly growing global iGaming market, which is projected to reach over $160 billion by 2026. The new platform is expected to launch in the first quarter of 2025 and will incorporate blockchain technology for enhanced security and flexibility in payment options, including cryptocurrencies.
180 life sciences公司于2024年10月4日宣布,已经恢复了符合纳斯达克最低股东权益要求,这是根据纳斯达克听证会在2024年7月1日作出的决定。公司将被持续监视一年以确保持续符合要求。然而,180 life sciences仍不符合纳斯达克的审计委员会要求,特别是至少需要三名独立董事。公司必须在其下一次年度股东大会或2025年5月7日之前满足这一要求,如果股东大会在此日期之前召开,则截止日期为2024年11月4日。未能遵守规定可能导致摘牌,但公司正在积极寻找合格的独立董事以恢复符合。此外,180 life sciences于2024年10月9日发布了一份关于重新符合权益规则以及...展开全部
180 life sciences公司于2024年10月4日宣布,已经恢复了符合纳斯达克最低股东权益要求,这是根据纳斯达克听证会在2024年7月1日作出的决定。公司将被持续监视一年以确保持续符合要求。然而,180 life sciences仍不符合纳斯达克的审计委员会要求,特别是至少需要三名独立董事。公司必须在其下一次年度股东大会或2025年5月7日之前满足这一要求,如果股东大会在此日期之前召开,则截止日期为2024年11月4日。未能遵守规定可能导致摘牌,但公司正在积极寻找合格的独立董事以恢复符合。此外,180 life sciences于2024年10月9日发布了一份关于重新符合权益规则以及其战略转向iGaming板块的新闻稿,这是在收购一家领先的iGaming平台技术之后。公司旨在利用这项技术进入预计到2026年将超过1600亿美元的全球迅速增长的iGaming市场。新平台预计将于2025年第一季度推出,并将采用区块链技术以增强安全性和支付选项的灵活性,包括加密货币。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息